Worldwide Clinical Trials
Yoshi Shinoki holds extensive experience in the pharmaceutical and medical device industries, currently serving as Executive Director and General Manager, Country Head at Worldwide Clinical Trials since January 2023, and as a Business Advisor for JETRO, focusing on regulatory and clinical development since April 2022. Additional roles include consulting at Pharma Initiative Support LLC, and serving as a Regulatory Expert at MEDISO. Previously, Yoshi held leadership positions at Global Regulatory Partners, ERT, Parexel, Covance, and Eli Lilly and Company, accumulating a wealth of expertise in clinical development, project leadership, and regulatory affairs. Yoshi began a career in clinical development at SAWAI Pharmaceutical Co., Ltd. and holds a Bachelor of Science degree in Pharmaceutical Sciences from Kyoto Pharmaceutical University.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
10 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.